Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00366-8/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=276355044&_hsenc=p2ANqtz--HUbXmt8w0oWQKA2zJjxhasHkXh74PgiauLNV5yD18_G4WQC7rOXSo8FnByqjQ5wBHYGUaO-asURS7S5HDrxJnqd2M2w&utm_content=276317812&utm_source=hs_email